Evidence map›Paper›PMID 41333554›Full record

ArticleJugan geon-gang gwa jilbyeong2023

[COVID-19 Waves and Their Characteristics in the Seoul Metropolitan Area (Jan 20, 2020-Aug 31, 2022)].

Jin Ho Ha, Ji Yeon Lee, So Young Choi, Sook Kyung Park

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A novel approach to estimatingFrontiers in public health · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Influencing Factors of Delayed Diagnosis of COVID-19 in Gangwon, South Korea.International journal of environmental research and public health · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jin Ho Ha질병관리청 수도권질병대응센터 감염병대응과.
Ji Yeon Lee질병관리청 수도권질병대응센터 감염병대응과.
So Young Choi질병관리청 수도권질병대응센터 감염병대응과.
Sook Kyung Park질병관리청 수도권질병대응센터 감염병대응과.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 virus, first identified in China in December 2019, spread rapidly. In January 2020, the World Health Organization officially declared a Public Health Emergency of International Concern. Due to the highly transmittable coronavirus disease 19 (COVID-19), each country has implemented various policy such as testing, quarantine contacts and social distancing. In the Republic of Korea, there have also been a large number of cases and deaths due to COVID-19. From January 20, 2020 to August 31, 2022, a total of 12,122,122 cases occurred in the capital region (52.3% of the national outbreak). The largest number of cases occurred during the 5th wave when the omicron variant spread, and the severity rate and mortality rate were the highest during 2nd wave. Until the 4th wave, the social distancing stage was applied differently depending on the situation in cities, but from the 5th wave, when the number of cases surged nationwide, it was converted to a critical patient-centered response system. Vaccines and therapeutics have been developed and has lifted recommendations for non-drug quarantine measures, but the COVID-19 pandemic is not ended yet. Efforts to overcome COVID-19 should be continued by looking back on the outbreak and response of COVID-19 and finding what has been done well and what to complement.

Indexed as

COVID-19Seoul metropolitan areaSocial distancing

Identifiers

PMID41333554
PMCPMC12479842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.